DoW Lung Cancer Idea Development Award
About
Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Idea Development Award (IDA) supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths and suffering from lung cancer. This mechanism promotes new ideas that are in the early stages of development and have the potential to yield impactful data and new avenues of investigation. Research must address at least one of the FY26 LCRP areas of emphasis. Distinctive Features: This FY26 LCRP IDA mechanism has a New Investigator category that is designed to allow applicants early in their faculty appointments to compete for funding separately from established investigators. Preliminary data to support the feasibility of the research hypotheses and research approaches are required; however, these data do not necessarily need to be derived from studies of lung cancer.
The DoW Lung Cancer Idea Development Award (IDA) is a prestigious funding opportunity designed for researchers pursuing innovative, high-risk/high-reward lung cancer research projects. This grant supports conceptually novel investigations in early-stage development that have the potential to accelerate progress toward eradicating lung cancer deaths and suffering. The program is ideal for researchers who have identified promising research directions but need initial funding to generate preliminary data and validate their hypotheses. The FY26 funding cycle particularly emphasizes research addressing specific areas of emphasis within the Lung Cancer Research Program (LCRP). A distinctive feature of this award is its New Investigator category, which allows early-career faculty members to compete separately from established researchers, creating equitable opportunities for emerging scientific talent. Researchers should apply if they have conceptually innovative ideas grounded in feasibility, even if preliminary data comes from non-lung cancer studies. This mechanism encourages bold scientific thinking and supports the development of novel research avenues that could yield impactful discoveries in lung cancer prevention, detection, and treatment.
Funding Facts
● Applications openDeadline
September 2, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Amount varies by cycle; contact program for details
Deadline
2026-09-02
Grant Type
federal
Application Cycle
Annual (FY26 cycle deadline September 2, 2026)
Best For
Researchers pursuing innovative, high-risk/high-reward lung cancer studies; early-career faculty through New Investigator category
Frequently Asked Questions
Who is eligible for DoW Lung Cancer Idea Development Award?
The program welcomes researchers at various career stages, with a dedicated New Investigator category for early-career faculty members. For specific eligibility requirements regarding institutional affiliation, citizenship status, and other criteria, please visit the official Department of War (DoW) or sponsoring agency website for the most current FY26 guidelines.
How much funding does DoW Lung Cancer Idea Development Award provide?
Specific funding amounts for the FY26 cycle have not been provided. Award amounts may vary based on research scope and project requirements. Contact the official program website or the sponsoring agency directly for current funding ranges and budget guidelines.
How do I apply for DoW Lung Cancer Idea Development Award?
Applications are typically submitted through the official DoW grant portal or relevant federal funding system. The application process generally requires a detailed research proposal, preliminary data supporting feasibility, and documentation of your research approach. Visit the official DoW Lung Cancer Research Program website for complete application instructions, required forms, and submission procedures for the FY26 funding cycle.
What can DoW Lung Cancer Idea Development Award funding be used for?
Funding supports early-stage, conceptually innovative lung cancer research that addresses at least one of the FY26 LCRP areas of emphasis. The award is designed to help researchers develop new ideas, generate preliminary data, and explore novel avenues of investigation that could lead to critical discoveries and major advancements in lung cancer research.
Last updated: July 5, 2026